で公開中です！ 詳しく見る
MEDPのアイコン

Medpace
MEDP

618.47 USD
-10.13
1.61%
終値時点 更新済み 10月16日 16:00 EDT
プレマーケット
時間外取引
618.47
0.00
0%
1日
-1.61%
5日間
0.94%
1か月
0.33%
3か月
14.97%
6か月
19.94%
年初来
8.31%
1年
18.66%
5年間
232.83%
10年間
1,996.51%
 

概要： Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

従業員数： 6,500

ヘルスケア 診断・リサーチ

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 70.6%
ニュートラル 29.4%
ネガティブ 0%
ポジティブ
Zacks Investment Research
一昨日
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Services stocks are likely familiar with Concentra Group (CON) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
ニュートラル
Zacks Investment Research
3 日前
Medpace (MEDP) Dips More Than Broader Market: What You Should Know
In the latest trading session, Medpace (MEDP) closed at $609.89, marking a -1.64% move from the previous day.
Medpace (MEDP) Dips More Than Broader Market: What You Should Know
ポジティブ
Seeking Alpha
3 日前
Medpace: A Shorter, Cleaner Backlog Is Being Mistaken For A Smaller One
Medpace Holdings is misunderstood due to its faster, cleaner backlog burn, which the market misinterprets as a growth ceiling rather than a quality upgrade. Q2 revenues rose 17.2% to $707.3M, with EBITDA margin improving beneath headline pass-through cost effects; guidance for FY26 was raised across revenue, EBITDA, and EPS. Customer prepayments fund operations and share buybacks, supporting EPS growth and providing a buffer against potential cash flow volatility as biotech funding rebounds.
Medpace: A Shorter, Cleaner Backlog Is Being Mistaken For A Smaller One
ニュートラル
Zacks Investment Research
10 日前
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
Medpace (MEDP) concluded the recent trading session at $602.9, signifying a -2.84% move from its prior day's close.
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
ニュートラル
Zacks Investment Research
17 日前
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, Medpace (MEDP) stood at $622.11, denoting a +1% move from the preceding trading day.
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts
ニュートラル
Zacks Investment Research
18 日前
CON or MEDP: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
CON or MEDP: Which Is the Better Value Stock Right Now?
ニュートラル
Business Wire
24 日前
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026. The Company will host a conference call the following morning, Thursday, October 22, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended yo.
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
ポジティブ
Zacks Investment Research
25 日前
Medpace (MEDP) Outperforms Broader Market: What You Need to Know
Medpace (MEDP) concluded the recent trading session at $624.2, signifying a +1.94% move from its prior day's close.
Medpace (MEDP) Outperforms Broader Market: What You Need to Know
ニュートラル
Zacks Investment Research
先月
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Medpace (MEDP) closed at $595.41, marking a +1.34% move from the previous day.
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
ポジティブ
Zacks Investment Research
先月
CON vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?
CON vs. MEDP: Which Stock Is the Better Value Option?
ニュースランキングを見る
価格チャートは Lightweight Charts™ を使用して実装されています